Vanguard Group Inc Elanco Animal Health Inc Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Vanguard Group Inc holds 48,323,246 shares of ELAN stock, worth $686 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
48,323,246
Previous 48,760,977
0.9%
Holding current value
$686 Million
Previous $590 Million
14.07%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding ELAN
# of Institutions
417Shares Held
452MCall Options Held
753KPut Options Held
671K-
Dodge & Cox San Francisco, CA82.9MShares$1.18 Billion0.53% of portfolio
-
Primecap Management CO Pasadena, CA50.2MShares$713 Million0.45% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$331 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A622MShares$313 Million11.21% of portfolio
-
Dimensional Fund Advisors LP Austin, TX20.5MShares$291 Million0.05% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.73B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...